Matches in SemOpenAlex for { <https://semopenalex.org/work/W113649872> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W113649872 endingPage "872" @default.
- W113649872 startingPage "869" @default.
- W113649872 abstract "One function of drug formularies is to allow health care providers to exert some control over spending. Decisions about whether to include a given medication in a formulary are based on estimates of its costs and effectiveness, relative to other treatment strategies. These decisions are made from a societal perspective, as opposed to that of individual patients, which sometimes results in conflicts. The clinical response to a medication often varies widely among subjects, which means that a small subgroup of patients might benefit dramatically, while others with the same disease do not. The result would be that a drug might appear not to be cost effective in an economic analysis, even though it is of proven value for some patients. New and innovative medications are assessed according to high standards of cost effectiveness, even though established treatments are wasteful of valuable health care resources. Moreover, quality-adjusted life-years (QALYs) discriminate against certain patient groups, including those with diseases that are associated with a high morbidity but a low mortality. Such patients often incur high indirect costs, including loss of employment income and costs incurred by family caregivers that QALYs do not reflect. Therefore, even though QALYs are transparent and widely applicable, they are not necessarily appropriate in the evaluation of a particular therapeutic intervention. A new paradigm should be developed for evaluating emerging therapies. An example would be a risk-sharing approach, whereby the pharmaceutical industry and public insurers share in the costs and rewards of introducing new treatments. This would have implications for the prices charged for new medications." @default.
- W113649872 created "2016-06-24" @default.
- W113649872 creator A5044626719 @default.
- W113649872 date "2002-01-01" @default.
- W113649872 modified "2023-10-15" @default.
- W113649872 title "Funding the New Biologics – Public Policy Issues in Drug Formulary Decision Making" @default.
- W113649872 cites W102765832 @default.
- W113649872 cites W1975411616 @default.
- W113649872 cites W2031296389 @default.
- W113649872 cites W2039044801 @default.
- W113649872 doi "https://doi.org/10.1155/2002/525819" @default.
- W113649872 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12522478" @default.
- W113649872 hasPublicationYear "2002" @default.
- W113649872 type Work @default.
- W113649872 sameAs 113649872 @default.
- W113649872 citedByCount "5" @default.
- W113649872 countsByYear W1136498722015 @default.
- W113649872 crossrefType "journal-article" @default.
- W113649872 hasAuthorship W113649872A5044626719 @default.
- W113649872 hasBestOaLocation W1136498721 @default.
- W113649872 hasConcept C100001284 @default.
- W113649872 hasConcept C100406419 @default.
- W113649872 hasConcept C111472728 @default.
- W113649872 hasConcept C127454912 @default.
- W113649872 hasConcept C138816342 @default.
- W113649872 hasConcept C138885662 @default.
- W113649872 hasConcept C142724271 @default.
- W113649872 hasConcept C144133560 @default.
- W113649872 hasConcept C159110408 @default.
- W113649872 hasConcept C160735492 @default.
- W113649872 hasConcept C162118730 @default.
- W113649872 hasConcept C162324750 @default.
- W113649872 hasConcept C17744445 @default.
- W113649872 hasConcept C199539241 @default.
- W113649872 hasConcept C2776125615 @default.
- W113649872 hasConcept C2779530757 @default.
- W113649872 hasConcept C2780665704 @default.
- W113649872 hasConcept C50522688 @default.
- W113649872 hasConcept C512399662 @default.
- W113649872 hasConcept C524218345 @default.
- W113649872 hasConcept C71924100 @default.
- W113649872 hasConceptScore W113649872C100001284 @default.
- W113649872 hasConceptScore W113649872C100406419 @default.
- W113649872 hasConceptScore W113649872C111472728 @default.
- W113649872 hasConceptScore W113649872C127454912 @default.
- W113649872 hasConceptScore W113649872C138816342 @default.
- W113649872 hasConceptScore W113649872C138885662 @default.
- W113649872 hasConceptScore W113649872C142724271 @default.
- W113649872 hasConceptScore W113649872C144133560 @default.
- W113649872 hasConceptScore W113649872C159110408 @default.
- W113649872 hasConceptScore W113649872C160735492 @default.
- W113649872 hasConceptScore W113649872C162118730 @default.
- W113649872 hasConceptScore W113649872C162324750 @default.
- W113649872 hasConceptScore W113649872C17744445 @default.
- W113649872 hasConceptScore W113649872C199539241 @default.
- W113649872 hasConceptScore W113649872C2776125615 @default.
- W113649872 hasConceptScore W113649872C2779530757 @default.
- W113649872 hasConceptScore W113649872C2780665704 @default.
- W113649872 hasConceptScore W113649872C50522688 @default.
- W113649872 hasConceptScore W113649872C512399662 @default.
- W113649872 hasConceptScore W113649872C524218345 @default.
- W113649872 hasConceptScore W113649872C71924100 @default.
- W113649872 hasIssue "12" @default.
- W113649872 hasLocation W1136498721 @default.
- W113649872 hasLocation W1136498722 @default.
- W113649872 hasLocation W1136498723 @default.
- W113649872 hasOpenAccess W113649872 @default.
- W113649872 hasPrimaryLocation W1136498721 @default.
- W113649872 hasRelatedWork W123908341 @default.
- W113649872 hasRelatedWork W2040946909 @default.
- W113649872 hasRelatedWork W2069899646 @default.
- W113649872 hasRelatedWork W2086274098 @default.
- W113649872 hasRelatedWork W2099143872 @default.
- W113649872 hasRelatedWork W2280273530 @default.
- W113649872 hasRelatedWork W2993037171 @default.
- W113649872 hasRelatedWork W3080508004 @default.
- W113649872 hasRelatedWork W3088578057 @default.
- W113649872 hasRelatedWork W36386386 @default.
- W113649872 hasVolume "16" @default.
- W113649872 isParatext "false" @default.
- W113649872 isRetracted "false" @default.
- W113649872 magId "113649872" @default.
- W113649872 workType "article" @default.